5:29 PM ET
8-K
Investor Presentation
Macrogenics Investor Presentation
MacroGenics, Inc. made available an updated corporate presentation on its website and as an exhibit to its 8-K filing. The presentation provides updated clinical program details and strategic priorities for the company's therapeutic candidates. The filing serves as a Regulation FD disclosure to ensure the updated information is available to the public and investors.